Health Care Higher as Mylan Surges -- Health Care Roundup

FeaturesDow Jones Newswires

Shares of health-care companies rose as an increased appetite for risk helped the biotech sub sector.

Shares of Mylan rallied after the Food and Drug Administration approved commercialization of a generic version of multiple-sclerosis drug Copaxone. The development weighed on shares of Copaxone maker Teva Pharmaceutical.

Continue Reading Below

Rob Curran,

(END) Dow Jones Newswires

October 04, 2017 16:56 ET (20:56 GMT)